Orexigen soars on Takeda deal; drug indexes rise

Shares of Orexigen jump on news that a Japanese pharmaceutical giant will commercialize Orexigen's new diet in North America, if and when it receives regulatory approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.